Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
status unknown

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

study id #: NCT00319007

condition: Adenomatous Polyposis Coli

status: status unknown

purpose:

The purpose of this study is to determine whether sulindac and VSL#3 – inulin, either combined or alone, are effective in treating or preventing adenoma development in the ileal anal pouch in patients with familial adenomatous polyposis.

intervention:
Drug: Sulindac (drug)
Drug: VSL#3 (probiotic)
Drug: Inulin (probiotic)

start date: April 2006

estimated completion: December 2006

last updated: August 10, 2007

phase of development: Phase 2

size / enrollment: 30

study design:
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention

primary outcomes:

  • Pouch mucosal proliferation index at 0, 1 and 2 months
  • Pouch mucosal apoptosis index at 0, 1 and 2 months

secondary outcomes:

  • Pouch mucosal Glutathione S transferases activity and isoenzyme levels at 0, 1 and 2 months
  • Faecal genotoxicity at 0, 1 and 2 months
  • Faecal cytotoxicity at 0, 1 and 2 months

inclusion criteria:
- Clinically or genetically proven familial adenomatous polyposis
- Restorative proctocolectomy with ileal pouch anal anastomosis

exclusion criteria:
- Chronic or acute renal or hepatic disease
- History of oesophageal, gastric or duodenal ulcers
- Known hypersensitivity to sulindac
- Daily use during the last three months of: - Aspirin
- Non-Steroidal Anti-Inflammatory Agents
- Probiotics

sponsor: Radboud University

contacts: Pieter Friederich, MD; 00-31-24-3614760; P.Friederich@mdl.umcn.nl
Fokko M Nagengast, PhD; 00-31-24-3614760; F.Nagengast@mdl.umcn.nl

investigators: Fokko M Nagengast, PhD

investigators: Fokko M Nagengast, PhD

locations: Netherlands

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close